New research carried out by UK pharmacy groups and academics from the University of East Anglia (UEA) suggests that community pharmacy-based care plans can help improve medicines adherence and quality of life for patients with long-term conditions – as well as saving the NHS money.

The second phase of collaboration between the UEA academics and the Community Pharmacy Future group – comprising Boots UK, LloydsPharmacy, Rowlands Pharmacy and Well Pharmacy – saw a large patient cohort in West Yorkshire receive a Pharmacy Care Plan (PCP) service, described as a ‘new model’ of care.

The PCP service consists of clinical tools for patients with long-term conditions including the Patient Activation Measure (PAM), which evaluates how confident a patient is in managing their care. The report authors say that moving a patient from the lowest activation level to the highest can reduce their healthcare costs by as much as a fifth.

Results

Over a 12-month period, 378 patients received the PCP service through 38 community pharmacies, including independents and multiples. The study authors claim the results point to statistically significant increases in patient activation, self-reported medication adherence and self-reported quality of life, and that a health economic analysis suggests the service is cost-effective.

The care model, described as ‘person-centred’, focuses on potential interactions between pharmacists and patients when the latter collect prescriptions, such as coaching, signposting and self-management guidance.

Key results from the study include:

  • 93 per cent of patients who attended the first appointment agreed one or more health goals with the pharmacist, of which almost 40 per cent achieved one or more goals
  • Improvement in PAM scores, systolic and diastolic blood pressure, adherence and quality of life
  • An estimated incremental cost-effectiveness ratio (ICER) of £8,495 (NICE considers an ICER below £20,000 to be cost-effective).

'Ever-increasing evidence base'

Clare Kerr, head of healthcare policy and strategy for Celesio UK, said: “The design, delivery and evaluation of this service has grown the ever-increasing evidence base for the value of community pharmacy, which was one of the key goals for this project.

“Either the full-service package, or elements of it, can easily be integrated into wider primary care models, supporting patients with multiple long-term conditions to become more activated and better able to self-care, improving their potential outcomes and reducing the cost of their care to the system.”

Jane Devenish, NHS standards and services pharmacist at Well, said: “With the NHS under unprecedented pressure to transform, community pharmacy care plans must become part of the integrated package of care commissioned by the NHS, so that each patient gets appropriate support to reach their health goals.”

 

Recommended

GPhC received six whistleblowing disclosures in 2017-18

The General Pharmaceutical Council received six whistleblowing disclosures between 1 April 2017 and 31 March 2018, accor...

CCA welcomes DHSC focus on pharmacy regulation

Proposals by the DHSC to steer pharmacy from ministerial legislation to professional regulation are to be welcomed, the ...




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.